Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological proยฎle of milnacipran suggested that the drug would be therapeutically eective and well tolerat
Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats
โ Scribed by Daisuke Mochizuki; Ryuichi Tsujita; Shinji Yamada; Koh Kawasaki; Yuji Otsuka; Shinji Hashimoto; Tsuyoshi Hattori; Yoshihisa Kitamura; Naomasa Miki
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 172 KB
- Volume
- 162
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Animal models of chronic pain serve as an experimental basis for testing new therapeutic interventions and for mechanistic investigations. In an animal model of chronic pain, based on the injection of formalin into the paw of a rodent, inhibitors of noradrenaline reuptake such as nisoxetine, nortrip
Considerable progress has been made in improving the tolerability of antidepressant drugs. The classical tricyclic antidepressants (TCA) are still, however, the standard for ecacy. The selective serotonin reuptake inhibitors are better tolerated that the tricyclics, but their ecacy in major depressi
This experiment investigated the effects of chronic treatment with serotonin reuptake inhibitors, fluvoxamine (10 mg/kg, i.p.) and sertraline (10 mgkg, i.p.), for 20 days on the behaviour, neurotransmitter concentrations and immune functions in the olfactory bulbectomized (OB) rat model of depressio